GO:0003084 positive regulation of systemic arterial blood pressure: Physiological Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003084 describes the biological process that increases the force with which blood travels through the systemic arterial circulatory system, as defined by QuickGO.
• Systemic arterial pressure is dynamically regulated by neural, hormonal, and local vascular mechanisms, with beta-adrenergic receptors playing a key role in resting arterial pressure regulation.
• Oscillations in systemic arterial pressure reflect underlying hemodynamic control mechanisms that can be studied in conscious animal models.
• Genetic factors such as cavin-1 can influence arterial function without necessarily altering systemic blood pressure, highlighting the complexity of blood pressure regulation.
• Obesity and heart failure with preserved ejection fraction impact muscle blood flow regulation during exercise, linking metabolic and cardiovascular control of arterial pressure.
• Understanding positive regulation of systemic arterial blood pressure is critical for developing therapies for hypertension, heart failure, and related cardiovascular diseases.
Description
Systemic arterial blood pressure is a vital physiological parameter that ensures adequate perfusion of organs and tissues. The Gene Ontology term GO:0003084, positive regulation of systemic arterial blood pressure, refers to the process that increases the force with which blood travels through the systemic arterial circulatory system. This process is tightly controlled by a complex interplay of neural, hormonal, and local factors, and its dysregulation contributes to major cardiovascular diseases. Research into this process spans from basic hemodynamic studies in animal models to clinical investigations in humans, aiming to elucidate the mechanisms that maintain or elevate blood pressure. Understanding how systemic arterial pressure is positively regulated is essential for identifying therapeutic targets for hypertension, heart failure, and other cardiovascular disorders.
positive regulation of systemic arterial blood pressure At A Glance
| GO ID | GO:0003084 |
|---|---|
| GO term | positive regulation of systemic arterial blood pressure |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the force of blood flow through the systemic arterial circulatory system |
| Related processes | Vascular tone regulation, cardiac output, fluid balance |
| Key regulators | Beta-adrenergic receptors, renin-angiotensin system, sympathetic nervous system |
| Physiological context | Maintenance of organ perfusion, response to stress and exercise |
What Is GO:0003084?
According to the Gene Ontology, GO:0003084 (positive regulation of systemic arterial blood pressure) is defined as the process that increases the force with which blood travels through the systemic arterial circulatory system. In other words, it encompasses all biological mechanisms that lead to an elevation in systemic arterial blood pressure, whether through increased cardiac output, vasoconstriction, or fluid retention. This term is a biological process and is distinct from negative regulation or general regulation of blood pressure.
Why Is positive regulation of systemic arterial blood pressure Important in Cell Biology?
Positive regulation of systemic arterial blood pressure is fundamental to human physiology because it ensures adequate blood supply to vital organs, particularly during challenges such as exercise or hemorrhage. However, chronic elevation of this process underlies hypertension, a leading risk factor for stroke, myocardial infarction, and kidney disease. Moreover, impaired regulation contributes to heart failure and shock. Studying GO:0003084 helps researchers understand the molecular and systemic mechanisms that control blood pressure, facilitating the development of targeted therapies.
• Maintains organ perfusion during physiological stress such as exercise or posture changes.
• Dysregulation leads to hypertension, a major cause of cardiovascular morbidity and mortality.
• Involved in the pathophysiology of heart failure with preserved ejection fraction.
• Plays a role in obesity-related cardiovascular complications.
• Beta-adrenergic receptor signaling is a key mechanism in resting arterial pressure regulation.
• Hemodynamic oscillations provide insights into autonomic control of blood pressure.
• Genetic factors such as cavin-1 can modulate arterial function independently of systemic pressure.
• Understanding this process aids in developing antihypertensive therapies.
• Relevant to intensive care medicine for managing shock and hypertension.
• Links to metabolic and adipokine regulation in pulmonary and systemic circulation.
What Happens During positive regulation of systemic arterial blood pressure?
Neural Control of Arterial Pressure
In simple terms: The brain and nerves quickly adjust blood pressure by signaling blood vessels to tighten or relax.
The sympathetic nervous system rapidly modulates systemic arterial pressure through beta-adrenergic receptors, which influence heart rate and vascular tone. Studies in humans show that resting arterial pressure regulation involves beta-adrenergic mechanisms, with sex and age differences observed. This neural control is essential for beat-to-beat adjustments in blood pressure.
Hormonal Regulation
In simple terms: Hormones like angiotensin II and aldosterone increase blood pressure by constricting vessels and retaining salt and water.
The renin-angiotensin-aldosterone system (RAAS) is a major hormonal pathway that positively regulates systemic arterial pressure. Although not directly cited in the provided references, this is a well-established mechanism. Adipokines may also influence blood pressure regulation, as suggested by studies on pulmonary hypertension and osteopenia.
Local Vascular Mechanisms
In simple terms: Blood vessels themselves can adjust their diameter to change blood pressure locally.
Local factors such as endothelial-derived nitric oxide and endothelin modulate vascular tone. In cavin-1-deficient mice, arterial dysfunction was observed but systemic blood pressure was maintained, indicating compensatory mechanisms. This highlights the complexity of local versus systemic regulation.
Hemodynamic Oscillations
In simple terms: Blood pressure naturally oscillates in waves, reflecting the interplay of heart and vessels.
In conscious rats, oscillations in systemic arterial pressure are generated by hemodynamic interactions, including cardiac output and vascular resistance. These oscillations can be analyzed to assess autonomic control and may be altered in disease states.
Integration in Disease States
In simple terms: In conditions like obesity and heart failure, blood pressure regulation becomes abnormal.
Obesity hypoventilation syndrome and heart failure with preserved ejection fraction are associated with altered blood flow regulation during exercise, which can impact systemic arterial pressure. Understanding these integrated responses is crucial for managing cardiovascular complications.
Key Genes Involved in GO:0003084 positive regulation of systemic arterial blood pressure
The following genes and proteins are involved in the positive regulation of systemic arterial blood pressure, based on experimental evidence from animal and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB1 | Beta-1 adrenergic receptor; mediates sympathetic effects on heart rate and contractility | Target for beta-blockers; studied in sex and age differences in pressure regulation |
| ADRB2 | Beta-2 adrenergic receptor; mediates vasodilation and bronchodilation | Involved in resting arterial pressure regulation |
| CAV1 | Caveolin-1; structural protein of caveolae; regulates signaling | Cavin-1 deficiency leads to arterial dysfunction but maintained blood pressure |
| CAVIN1 | Cavin-1; component of caveolae; modulates vascular function | Studied in knockout mice for arterial function |
| REN | Renin; rate-limiting enzyme of RAAS | Key regulator of blood pressure; not directly cited but well-known |
| AGT | Angiotensinogen; precursor of angiotensin peptides | RAAS component; potential target for hypertension |
| ACE | Angiotensin-converting enzyme; produces angiotensin II | Target for ACE inhibitors |
| AGTR1 | Angiotensin II receptor type 1; mediates vasoconstriction | Target for ARBs |
| NOS3 | Endothelial nitric oxide synthase; produces NO for vasodilation | Modulates vascular tone; not directly cited |
| EDN1 | Endothelin-1; potent vasoconstrictor | Involved in hypertension; not directly cited |
| LEP | Leptin; adipokine that influences sympathetic activity | Linked to obesity-related hypertension |
| ADIPOQ | Adiponectin; adipokine with vasoprotective effects | Studied in pulmonary hypertension and osteopenia |
| NPPA | Atrial natriuretic peptide; promotes natriuresis and vasodilation | Counter-regulatory to RAAS; not directly cited |
| NPPB | Brain natriuretic peptide; marker of heart failure | Used clinically; not directly cited |
| VEGFA | Vascular endothelial growth factor; affects vascular permeability and tone | Potential role in pressure regulation; not directly cited |
| HIF1A | Hypoxia-inducible factor 1-alpha; regulates vascular responses | May influence blood pressure in hypoxia; not directly cited |
| ACE2 | Angiotensin-converting enzyme 2; counterbalances RAAS | Important in COVID-19 and hypertension; not directly cited |
How Is positive regulation of systemic arterial blood pressure Regulated?
Positive regulation of systemic arterial blood pressure is itself regulated by feedback loops involving baroreceptors, chemoreceptors, and hormonal signals. For instance, beta-adrenergic receptors are modulated by age and sex, affecting resting arterial pressure. Additionally, adipokines such as leptin and adiponectin can influence sympathetic outflow and vascular function, linking metabolic status to blood pressure control. Hemodynamic oscillations may also reflect autonomic regulation. Dysregulation of these pathways can lead to sustained hypertension or hypotension.
positive regulation of systemic arterial blood pressure and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADRB1 | Hypertension, heart failure | Knockout or point-mutation mice; beta-blocker studies |
| CAVIN1 | Arterial dysfunction | Knockout mice (cavin-1-deficient) |
| LEP | Obesity-related hypertension | Ob/ob mice; leptin infusion models |
| AGTR1 | Hypertension, cardiovascular remodeling | Knockout mice; ARB treatment models |
| NOS3 | Endothelial dysfunction, hypertension | eNOS knockout mice |
Hypertension and Cardiovascular Disease
Chronic positive regulation of systemic arterial blood pressure contributes to hypertension, a major risk factor for stroke, heart attack, and kidney failure. Beta-adrenergic receptor sensitivity changes with age and sex, influencing hypertension risk. Targeting these pathways is a cornerstone of antihypertensive therapy.
Heart Failure with Preserved Ejection Fraction (HFpEF)
In HFpEF, impaired regulation of muscle blood flow during exercise is linked to abnormal systemic arterial pressure responses. Obesity further exacerbates this condition, complicating management.
Obesity and Metabolic Syndrome
Obesity hypoventilation syndrome and metabolic syndrome are associated with altered adipokine profiles that can increase sympathetic activity and blood pressure. Adipokines like adiponectin may also play a role in pulmonary hypertension and systemic osteopenia.
Critical Illness and Shock
In intensive care, positive regulation of systemic arterial pressure is crucial for maintaining organ perfusion in shock states. Hemodynamic monitoring and vasopressor therapy are guided by understanding these mechanisms.
From positive regulation of systemic arterial blood pressure-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate systemic arterial pressure? | Knockout mouse (e.g., cavin-1 KO) |
| What is the effect of a point mutation in gene Y on blood pressure? | Point-mutation knock-in mouse |
| How does overexpression of gene Z affect arterial pressure? | Transgenic overexpression mouse |
| Can we tag a protein to track its role in blood pressure regulation? | Tagged knock-in mouse |
| What is the role of beta-adrenergic receptors in resting pressure? | Human studies with beta-blockers |
| How do hemodynamic oscillations reflect autonomic control? | Conscious rat telemetry |
How to Study the positive regulation of systemic arterial blood pressure Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Telemetry | Continuous arterial pressure | Conscious animal studies |
| Knockout mice | Gene function in vivo | Cavin-1 deficiency |
| Beta-blocker infusion | Beta-adrenergic contribution | Human resting pressure |
| Multi-omics | Global molecular changes | Atherosclerosis mechanism |
| Exercise testing | Blood flow regulation | HFpEF patients |
| Adipokine profiling | Hormonal influence | Obesity and hypertension |
| Intensive care monitoring | Hemodynamic support | Shock management |
Hemodynamic Monitoring
Telemetry and catheter-based systems allow continuous measurement of systemic arterial pressure in conscious animals, revealing oscillations and responses to stimuli. These methods are essential for quantifying positive regulation.
Genetic Knockout and Transgenic Models
Knockout mice, such as cavin-1-deficient mice, help dissect the role of specific genes in arterial function and blood pressure regulation. Overexpression and knock-in models further refine understanding.
Human Physiological Studies
Studies in humans, such as those using beta-adrenergic receptor agonists/antagonists, elucidate mechanisms of resting arterial pressure regulation and sex/age differences.
Multi-omics and Bioinformatics
Multi-omics approaches, including transcriptomics and proteomics, can identify novel regulators of blood pressure. For example, multi-omics revealed mechanisms of DanxiaTiaoban decoction in atherosclerosis, a related cardiovascular condition.
How CRISPR Can Be Used to Study GO:0003084 positive regulation of systemic arterial blood pressure
Knockout
CRISPR knockout of candidate genes (e.g., Adrb1, Cavin1) in mice or cell models can determine their necessity for positive regulation of systemic arterial blood pressure. For instance, cavin-1 knockout mice show arterial dysfunction.
Point Mutation
Introducing point mutations in genes like ADRB1 can mimic human polymorphisms and assess their impact on receptor function and blood pressure regulation.
Knock-in
Knock-in of tagged or reporter genes allows real-time tracking of protein localization and dynamics in vascular tissues, enhancing understanding of regulatory mechanisms.
Overexpression
Overexpression of genes such as renin or angiotensinogen can induce hypertension in animal models, validating their role in positively regulating systemic arterial pressure.
How EDITGENE Supports positive regulation of systemic arterial blood pressure Research
Researchers studying positive regulation of systemic arterial blood pressure-related genes often need to determine whether a candidate gene is causally involved in the process or merely a biomarker. This requires precise genetic manipulation, which is where EDITGENE's services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of systemic arterial blood pressure research.
Frequently Asked Questions About positive regulation of systemic arterial blood pressure
What is GO:0003084?
GO:0003084 is the Gene Ontology term for positive regulation of systemic arterial blood pressure, defined as the process that increases the force with which blood travels through the systemic arterial circulatory system.
What genes are involved in positive regulation of systemic arterial blood pressure?
Key genes include ADRB1, ADRB2, CAVIN1, REN, AGT, ACE, AGTR1, and NOS3, among others, based on experimental evidence.
How is systemic arterial blood pressure regulated?
It is regulated by neural, hormonal, and local mechanisms, including beta-adrenergic signaling, the renin-angiotensin-aldosterone system, and endothelial factors.
What diseases are associated with abnormal systemic arterial blood pressure regulation?
Hypertension, heart failure, obesity-related cardiovascular disease, and shock are major associated conditions.
What animal models are used to study systemic arterial blood pressure?
Conscious rat telemetry, knockout mice (e.g., cavin-1-deficient), and transgenic models are commonly used.
How does beta-adrenergic signaling affect blood pressure?
Beta-adrenergic receptors modulate heart rate and vascular tone, and their sensitivity changes with age and sex, influencing resting arterial pressure.
What is the role of cavin-1 in arterial pressure?
Cavin-1 deficiency in mice leads to arterial dysfunction but maintained systemic blood pressure, suggesting compensatory mechanisms.
Can CRISPR be used to study blood pressure regulation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect gene function in blood pressure regulation.
What is the link between obesity and systemic arterial pressure?
Obesity alters adipokine profiles and sympathetic activity, contributing to hypertension and heart failure.
How do hemodynamic oscillations relate to blood pressure regulation?
Oscillations in systemic arterial pressure reflect autonomic control and can be measured in conscious animals to study regulation.
Conclusion
GO:0003084, positive regulation of systemic arterial blood pressure, is a critical biological process that maintains organ perfusion but also contributes to cardiovascular disease when dysregulated. Research using genetic, physiological, and multi-omics approaches continues to unravel its complexity. Targeting key regulators such as beta-adrenergic receptors and RAAS components remains a therapeutic cornerstone. EDITGENE's CRISPR services empower researchers to functionally validate candidate genes and accelerate discoveries in blood pressure regulation.
References
- 1. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 2. Ma Y et al.. 2025. Multi-omics and experimental validation reveal the mechanism of DanxiaTiaoban decoction in treating atherosclerosis.. Phytomedicine 147:157216 PMID: 40916281
- 3. Swärd K et al.. 2014. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice.. PLoS One 9(3):e92428 PMID: 24658465
- 4. Kochetkova EA et al.. 2018. [Issues of Adipokine Regulation in Idiopathic Pulmonary Arterial Hypertension and Systemic Osteopenia].. Kardiologiia PMID: 29466196
- 5. Janssen BJ et al.. 1995. Hemodynamic basis of oscillations in systemic arterial pressure in conscious rats.. Am J Physiol 269(1 Pt 2):H62-71 PMID: 7631875
- 6. Vultur MA et al.. 2025. A Multidisciplinary Approach to Obesity Hypoventilation Syndrome: From Diagnosis to Long-Term Management-A Narrative Review.. Diagnostics (Basel) 15(17) PMID: 40941607
- 7. Hart EC et al.. 2011. Sex and ageing differences in resting arterial pressure regulation: the role of the β-adrenergic receptors.. J Physiol 589(Pt 21):5285-97 PMID: 21859824
- 8. Ratchford SM et al.. 2022. The impact of obesity on the regulation of muscle blood flow during exercise in patients with heart failure with a preserved ejection fraction.. J Appl Physiol (1985) 132(5):1240-1249 PMID: 35421322
